Saratoga Investment Corp. NT 23
Limited financial coverage for SAB.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Range $20 – $20
Price Chart
About the company
Saratoga Investment Corp. offers capital solutions to mid-sized businesses, encompassing both loan facilities and direct equity investments.
- IPO
- 2016
- HQ
- ES
Get TickerSpark's AI analysis on SAB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $211000.00
- 52W Low
- $25.62
- 50D MA
- $189334.28
- 200D MA
- $188533.58
- Beta
- 0.00
- RSI (14)
- 68
- Avg Volume
- 69.92K
No earnings-call transcripts are available for SAB yet.
- Free Float
- 0.0%
- Shares Outstanding
- 5.88M
- Float Shares
- 0
Held by 12 ETFs
Biggest fund positions in SAB by dollar value.
Our SAB coverage
Recent articles, reports, and earnings notes.
No research on SAB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SAB report →SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
globenewswire.com · Nov 5
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
globenewswire.com · Oct 29
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
globenewswire.com · Oct 29
SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody Platform
marketbeat.com · Oct 23
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
globenewswire.com · Oct 22
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
globenewswire.com · Oct 14
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
globenewswire.com · Oct 13
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
globenewswire.com · Oct 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.